StockData

Bon Natural Life Ltd (BON) shareholders

BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 23, 2026Score 0/30
$1.07−0.02 (-1.83%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

Ownership

Who owns Bon Natural Life's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
jing liuChief Technology Officer, Director1,4960.02%Apr 10, 2026
Yongwei HuChief Executive Officer, Director, 10% owner80,1770.99%Apr 10, 2026
Yingchun XueChief Operating Officer1200.00%Apr 10, 2026
Xin MaChief Financial Officer––Apr 10, 2026
Chen WenjuanChief Marketing Officer800.00%Apr 10, 2026
Gao ZhixiangDirector––May 15, 2026
Jing Veronica ChenDirector––Apr 23, 2026
Jianjun GaoDirector––Apr 10, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.17%
0M shares short
Days to cover
1.1
At 0M shares a day
Change since last report
-14.2%
From 0M shares
Short volume, 20 days
45.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bon Natural Life's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,718 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?